Because it is linked to serious and often life-threatening side effects, Genentech, a Roche subsidiary and manufacturer of , faces countless lawsuits filed by those injured by the drug.

Used both in conjunction with chemotherapy and alone, Avastin is an intravenous medicine that slows the growth and spread of cancerous cells in the body.  First approved by the U. S. Food and Drug Administration (FDA) in 2004 for use in patients with colon cancer, Avastin was granted approval for lung cancer in 2006, for metastatic breast cancer in 2008, and for and brain (glioblastoma) cancer in 2009.

However, on November 18, 2011, Commissioner Margaret A. Hamburg, M. D., announced the withdrawal of the FDA’s approval of Avastin’s metastatic breast cancer indication after concluded that the drug was “not shown to be safe and effective in breast cancer patients.”  Studies revealed that Avastin subjected women to severe and life-threatening risks, such as high blood pressure, hemorrhaging, heart failure, and perforations in the nose, stomach, and intestines, without providing any benefits.

Additional studies revealed a higher death rate in patients being treated with Avastin in conjunction with chemotherapy in comparison to those receiving only chemotherapy.  Published in The Journal of the American Medical Association, the study concluded the risk of death is 2.5% in patients receiving a combined treatment versus 1.7% when chemotherapy is used alone. Plaintiff’s across the country and abroad have filed lawsuits against Genentech and its parent company, claiming the manufacturer failed to adequately warn users of Avastin’s dangers and for gouging its users with a price tag of over $88,000 per year for treatment for little or no benefit.

Often, Avastin is prescribed “off-label” for age-related macular degeneration (AMD), the leading cause of blindness in people over 50, as a cheaper alternative to Lucentis, the FDA-approved drug for AMD. A study conducted by Johns Hopkins University presented at a meeting of the Association for Research in Vision and Ophthalmology (ARVO) on May 4, 2011, revealed Avastin-used for off-label treatment of eye increases the risk of stroke and death.   Patients suffering from eye infections and adverse side effects obtained from Avastin injections have already filed .

Have you suffered from Avastin-related side effects? Any individual or the relative of an individual who has suffered due to Avastin’s side effects is permitted to file a lawsuit.  The lawyers can help you determine whether you are qualified to seek compensation.  You may be eligible to seek reimbursement for medical expenses, compensation for pain and suffering, and punitive damages (compensation granted for losses suffered).

It is essential to hire an experienced and effective lawyer who can file your case. If you need further information about the harmful side effects of Avastin or legal advice concerning personal injury matters, we invite you to contact us or to fill out our form on this website for a free case evaluation.